Dr. Richard and Vera Siegel Translational Award for Advances in Medical Science Award Application

Applications are now open.

The Dr. Richard and Vera Siegel Translational Award for Advances in Medical Science

The Translational Award for Advances in Medical Science, endowed by Dr. Richard Siegel and his wife, Vera Siegel, honors researchers who have made significant strides in bridging the gap between basic research and clinical application. This award celebrates advancements that have the potential to improve patient care and treatment outcomes.

Award Guidelines 

– Applications will be due by December 31, 2024.

– Winners will be selected by February 1, 2025.

– Scholars are expected to present at the 2025 Colloquium.

– Scholars will receive a monetary prize and statuette.

Please enable JavaScript in your browser to complete this form.
Step 1 of 4
I am:

Contact Information

Please provide your contact details.
Name

Gregory Paul Lenardo Basic Science Award Application

Applications are now open.

The Gregory Paul Lenardo Basic Science Award

The Gregory Paul Lenardo Basic Science Award is dedicated to honoring researchers who have made significant contributions to our understanding of cellular and molecular biology. Endowed by Dr. Michael Lenardo in loving memory of his brother, Gregory Paul Lenardo, the award reflects the commitment to fostering innovation and excellence in scientific research.

Award Guidelines 

– Applications will be due by December 31, 2024.

– Winners will be selected by February 1, 2025. 

– Scholars are expected to present at the 2025 Colloquium.

– Scholars will receive a monetary prize and statuette.

Please enable JavaScript in your browser to complete this form.
Step 1 of 4
I am:

Contact Information

Please provide your contact details.
Name

The Lasker Foundation

The Lasker Foundation

The Lasker Foundation aims to improve health by accelerating support for medical research through recognition of research excellence, advocacy, and education. 

They celebrate the contributions of scientists, clinicians, and public servants who have made major advances in the understanding, diagnosis, treatment, cure, or prevention of human disease. The Lasker Foundation’s programs educate the public and promote scientific collaboration, and advocate for a healthier world through medical research.

The Lasker Foundation and IBRA have been partners over the past decade.

Lasker Lessons in Leadership

Lasker Lessons in Leadership provide strategies for developing leadership skills, stimulate a sense of leadership responsibility, and encourage NIH trainees and tenure track faculty to seek out opportunities to be a leader in their biomedical careers. The series is a collaboration with the International Biomedical Research Alliance, the Lasker Foundation, and the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program. Browse through upcoming and past events below.

An Interview With Yuk Ming Dennis Lo

Yuk Ming Dennis Lo was the featured speaker at the Spring 2024 Lasker Lessons in Leadership event. Lo discussed his scientific training in the UK, establishing a lab in Hong Kong, and crossing the boundaries between academia and industry. He was joined by Yasemin...

Lasker Lessons in Leadership with Yuk Ming Dennis Lo

Yuk Ming Dennis Lo was the featured speaker at the Spring 2024 Lasker Lessons in Leadership event. Lo discussed his scientific training in the UK, establishing a lab in Hong Kong, and crossing the boundaries between academia and industry. He was joined by Yasemin...

Past Events

A Interview with Lasker Laureate Prof. Yuk Ming Dennis Lo

May 16, 2024 at the National Institutes of Health, Bethesda, MD, USA

Interviewees: NIH-Gates Cambridge Scholars Yasemin Cole and Henry Taylor and NIH-Rhodes Scholar Kritika Singh


A Conversation with MacArthur Fellow Prof. Michelle Monje-Deisseroth, MD/PhD and Lasker Laureate Prof. Karl Deisseroth, MD/PhD

October 17, 2023 at Stanford University, Palo Alto, CA, USA

Interviewees: NIH-Gates Cambridge Scholar Haillie Gaitsch (MD/PhD Candidate ) & NIH-Cambridge Scholar John Hancock (MD/PhD Candidate)


A Conversation with Mr. Kenneth C. Frazier, Executive Chairman of the Board and Former CEO, Merck & Co., Inc.

June 15, 2022 at the National Institutes of Health, Bethesda, MD, USA

Interviewer: NIH-Cambridge Scholar Jasmine Mack, MPH, MS (PhD Candidate)


Harvey J. Alter: HCV The End Of The Beginning Could This Be The Beginning Of The End


Cynthia Kenyon: Life Lessons from a Small Creature


Wendy Chung: My Life as a Zebra Hunter


David Rubenstein interviews Anthony Fauci: An Interview on Leadership and a Career in Public Health


George Yancopoulos: My Scientific Story – From Academia to Starting and Building a Major Biotech Company


Mary Woolley: Winning Hearts and Minds in Science


Anne Schuchat: Going Public: From the Bedside to the Big Picture Lessons in Leadership from a Career in Public Health


Regis Kelly: Academia and the Private Sector – An Odd Couple?


Jeremy Nathans: A Conversation on Leadership and Career Path


Craig Thompson: The Difference between Leadership and Management


Linda Fried: How Scientists Become Effective Communicators


Dan Littman: The Art of Publishing


Ralph Snyderman: From Brooklyn to Lab Bench to Board Room – Lessons Learned


NIH Oxford-Cambridge Scholars and Alumni Visit Regeneron for Insightful Scientific Exchange

NIH Oxford-Cambridge Scholars and Alumni Visit Regeneron for Insightful Scientific Exchange

On September 26, 2024, the NIH Oxford-Cambridge Scholars and Alumni embarked on an enriching visit to Regeneron, fostering connections between future scientific leaders and established experts in biotechnology. Hosted at Regeneron’s headquarters, the visit featured a full day of discussions, presentations, and networking opportunities that highlighted the ongoing collaborative spirit between academic and industry research.

The day began with a warm welcome and light breakfast, followed by an introduction to Regeneron and its prestigious Postdoctoral Program by Susan Croll, Co-Director of the program, and Devon Southwick, Postdoctoral Program Coordinator. The Scholars had the chance to learn about cutting-edge research opportunities and career pathways at Regeneron.

Regeneron scientists Ido Rippon, Judith Altarejos, Chunguang Guo, Kalyani Nambiar, and David DiLillo presented their work in a series of engaging talks, offering insights into the research driving the company’s innovative efforts in immunology, genetics, neuroscience, and oncology.

Lunch provided an opportunity for informal discussions before transitioning into the afternoon agenda, which spotlighted Scholar-led initiatives. Anagha Krishnan, Hannah Dada, and Chiara Benetollo led a presentation on the “Science Unlocked” program. System-impacted youth, particularly in STEM, face poorer educational outcomes due to a lack of hands-on learning opportunities in prison curriculums, prompting the creation of “Science Unlocked”, a series of monthly science demonstrations at the Youth Services Center in DC. IBRA Director of Engagement and Events, Alexandra Ambrico, introduced IBRA’s mission, impact and reach, and their new network for international researchers. 

A key highlight of the afternoon was the Scholars’ scientific presentations, where Anagha Krishnan, Hannah Dada, Sooraj Achar, and Henry Taylor shared their cutting edge research. Alumni Hannah Mason and Adjoa Smalls-Mantey discussed their research and careers. These sessions provided a platform for both Scholars and Alumni to showcase their work and engage in thought-provoking discussions with Regeneron scientists.

The day concluded with a closing reception, offering the group an opportunity to network with George Yancopoulos, Regeneron’s co-founder and Chief Scientific Officer, and other members of the Regeneron team.

This visit underscores the importance of collaboration between industry and academia in advancing biomedical research. Both Scholars and Regeneron scientists gained valuable insights, and the event highlighted the alignment of their scientific goals, particularly in the realms of biomedical innovation and education. We would like to extend our heartfelt thanks to Regeneron for their generous support and commitment, which has been instrumental in advancing our efforts to make a meaningful impact in supporting biomedical research leaders.

Dr. Michael Lenardo Receives 2024 Director’s Award

Dr. Michael Lenardo Receives 2024 Director’s Award

From time to time, individuals who have made extraordinary contributions to the NIH Oxford-Cambridge Scholars Program are singled out to receive special recognition with the “Director’s Award.” Honorees are selected based on their dedication to the mission of cultivating the next generation of scientists and their selfless service to the Scholars Program.

The 2024 Director’s Award was presented to Dr. Michael Lenardo.

Dr. Lenardo is not only an accomplished immunologist, having led his group to discover four distinct diseases and helped advance diagnostics and therapies for many more, but he is also a world-recognized international biomedical research leader. A AAAS Fellow, a Member of the National Academy of Science and the National Academy of Medicine, a Fellow of the Academy of Medical Sciences of Great Britain, and an Officer of the Most Excellent Order of the British Empire (O.B.E.) conferred by Queen Elizabeth II, he remains a trailblazer in immunology and biomedical research, as well as an incredible mentor and supporter of trainees at the NIH and collaborating universities.

Dr. Lenardo co-founded the NIH-Oxford Cambridge Scholars Program, the NIH-UPenn Immunology Program, the NIH-Marshall Scholars, the NIH-Rhodes Scholars, the National M.D./Ph.D. Partnership Program, and the NIH-Institut Pasteur Infectious Disease and Immunology Program. He was also instrumental in catalyzing the creation of the International Biomedical Research Alliance and remains an advisor, ally, and advocate for our organization, a role we hope he continues for many years to come.

Additionally, Dr. Lenardo has been a dedicated mentor and friend to many in the Program. His infectious energy and spirit have inspired countless students, including those who joined the top PhD program in the world due to his influence. Dr. Lenardo will soon begin his new role as Chief Scientific Officer at Calico Labs.

Congratulations to Dr. Michael Lenardo on this well-deserved honor!